Penny Stock Conduit Pharmaceuticals has recently signed a licensing agreement with AstraZeneca for multiple assets. This exclusive deal will allow Conduit Pharmaceuticals to access various assets owned by AstraZeneca. The partnership between the two companies is expected to bring about significant benefits for both parties.